Exclusive biopharma, health policy, and life science analysis. Start your 30-day free trial today.

Catch up on the latest must-read coverage and analysis

advertisement

Most Popular

Coronaviruses are ‘clever’: Evolutionary scenarios for the future of SARS-CoV-2
6 approval decisions that will make or break Califf’s first year at the FDA
By altering the blood type of lungs, researchers raise the possibility of universal organs for transplants
Why Covid-19 vaccines are a freaking miracle
Some newly public biotech companies are trading below cash. Is it as bad as it looks?

Toxic levels of pharmaceuticals threaten the health of the world’s rivers
A federal appeals court once again casts doubt on ‘skinny labels’ and generic drug access
BioNTech details new plans for Covid-19 vaccine production in Africa, but meets with skepticism

advertisement

Events

CRISPR Quest Feb. 24, 2022
2022 STAT Breakthrough Science Summit Mar. 31, 2022
Leading Digital Transformation in Health Care Feb. 07, 2022

See More Events

STAT Reports

Deep-dive reports into the breakthroughs that are revolutionizing health care.

Continuous glucose monitoring: how it’s advancing diabetes care
The ‘shroom boom’: The meteoric rise of the psychedelic medicine industry
2021 Update: Ranking biotech’s top venture capital firms

See More Reports